Key result
This review highlights the most important studies published in the European Heart Journal-Cardiovascular Imaging in 2020, focusing on valvular heart disease, heart failure, and cardiomyopathies.
This review summarizes key cardiovascular imaging studies published in 2020 concerning valvular heart disease, heart failure, cardiomyopathies, and congenital heart disease.
Alerts clinicians to 2020 imaging advances in valvular disease and HF; leaves open prospective validation before practice change.
The European Heart Journal-Cardiovascular Imaging was launched in 2012 and has during these years become one of the leading multimodality cardiovascular imaging journal. The journal is now established as one of the top cardiovascular journals and is the most important cardiovascular imaging journal in Europe. The most important studies published in our Journal from 2020 will be highlighted in two reports. Part II will focus on valvular heart disease, heart failure, cardiomyopathies, and congenital heart disease. While Part I of the review has focused on studies about myocardial function and risk prediction, myocardial ischaemia, and emerging techniques in cardiovascular imaging.
No takes yet. Share an insight, caveat, or question.
Plein et al. (2013) conducted a review in Valvular heart disease, heart failure, cardiomyopathies, and congenital heart disease. This review highlights the most important studies published in the European Heart Journal-Cardiovascular Imaging in 2020, focusing on valvular heart disease, heart failure, and cardiomyopathies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: